✦ LIBER ✦

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

✍ Scribed by Jean-Pierre Julien; Nina Bijker; Ian S Fentiman; Johannes L Peterse; Vincenzo Delledonne; Philippe Rouanet; Antoine Avril; Richard Sylvester; Françoise Mignolet; Harry Bartelink; Joop A Van Dongen

Book ID: 117312983
Publisher: The Lancet
Year: 2000
Tongue: English
Weight: 93 KB
Volume: 355
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(99)06341-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy in breast-conserving treatm

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

✍ J.P Julien; N Bijker; I.S Fentiman; V Delledonne; P Rouanet; A Avril; R Sylveste 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 21 KB

The role of radiotherapy in breast conse

The role of radiotherapy in breast conserving treatment of ductal carcinoma in situ (DCIS): First results of EORTC trial 10853

✍ J. Julien; N. Bijker; R. Sylvester; I. Fentiman; B. Salvadori; P. Rouanet; A. Av 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 148 KB

217 Adjuvant Radiotherapy After Breast-c

217 Adjuvant Radiotherapy After Breast-conserving Surgery for Ductal Carcinoma in Situ – Fifteen-year Results of the EORTC Randomized Phase III Trial 10853

✍ M. Donker; S. Litiére; G. Werutsky; J.P. Julien; I.S. Fentiman; R. Agresti; P. R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Breast-conserving treatment with or with

Breast-conserving treatment with or without radiotherapy for ductal carcinoma in situ (DCIS): ten-year results of European Organisation for Research and Treatment of Cancer (EORTC) randomized phase III trial 10853

✍ N. Bijker; Meijnen; J. Bogaerts; J.L. Peterse 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Breast-Conserving Treatment With or With

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

✍ Donker, M.; Litiere, S.; Werutsky, G.; Julien, J.-P.; Fentiman, I. S.; Agresti, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 163 KB

2–45 Breast-Conserving Treatment With or

2–45 Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

✍ Wong, J.S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB